Previous Close | 14.40 |
Open | 14.24 |
Bid | 14.50 x 1000 |
Ask | 16.25 x 900 |
Day's Range | 14.01 - 15.34 |
52 Week Range | 12.54 - 33.49 |
Volume | |
Avg. Volume | 462,150 |
Market Cap | 565.358M |
Beta (5Y Monthly) | 0.82 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for BCYC
One thing we could say about the analysts on Bicycle Therapeutics plc ( NASDAQ:BCYC ) - they aren't optimistic, having...
Company's cash and cash equivalents stand at $572.1 million as of September 30, 2023
The last few months have been tough for investors, as stocks have mostly been falling since mid-summer. To wit, the S&P 500, which peaked at the end of July, is down close to 8% from that high. The headwinds behind these losses are well-known: stubborn inflation, the Fed’s persistence in sticking to a high-interest-rate, tight-money policy in response, a worsening geopolitical situation and related rising oil prices, increasing bond yields, and the uncertainty of an upcoming election; it would b